Lexicon Pharmaceuticals, Inc. (LXRX)

NASDAQ: LXRX · Real-Time Price · USD

1.560

-0.060 (-3.70%)

At close: Mar 18, 2026, 4:00 PM EDT

1.550

-0.010 (-0.62%)

After-hours: Mar 18, 2026, 7:51 PM EDT

Lexicon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	34.33	66.66	22.47	46.35	64.07
Short-Term Investments	61.9	171.3	147.56	92.01	22.68
Cash & Short-Term Investments	96.23	237.96	170.03	138.36	86.74
Cash Growth	-59.56%	39.95%	22.89%	59.50%	-43.04%
Accounts Receivable	2.38	3.47	1.01	0.03	0.01
Inventory	0.28	0.23	0.38	-	-
Other Current Assets	3	4.53	5.13	2.48	2.16
Total Current Assets	101.9	246.19	176.55	140.87	88.92
Net Property, Plant & Equipment	9.18	7.32	7.51	8.48	3.45
Goodwill	44.54	44.54	44.54	44.54	44.54
Other Long-Term Assets	29.37	0.37	0.83	0.41	-
Total Assets	184.99	298.42	229.43	194.3	136.91
Accounts Payable	3.08	14.8	14.39	10.4	9.15
Accrued Expenses	13.19	30.45	17.16	12.78	12.97
Current Portion of Long-Term Debt	4.6	-	-	-	-
Total Current Liabilities	20.87	45.25	31.55	23.17	22.12
Long-Term Debt	49.41	100.3	99.51	48.58	-
Long-Term Leases	-	-	-	5.42	1.19
Other Long-Term Liabilities	7.17	6.92	5.27	-	-
Total Long-Term Liabilities	56.58	107.22	104.77	54	1.19
Total Liabilities	77.45	152.47	136.32	77.18	23.31
Common Stock	0.37	0.36	0.25	0.19	0.15
Treasury Stock	-5.19	-4.62	-2.89	-2.06	-7.52
Additional Paid-in Capital	2,130	2,117	1,863	1,709	1,609
Accumulated Other Comprehensive Income	0.03	0.12	0.03	-0.43	-0.01
Retained Earnings	-2,018	-1,967	-1,767	-1,590	-1,488
Shareholders' Equity	107.54	145.95	93.11	117.12	113.6
Total Liabilities & Equity	184.99	298.42	229.43	194.3	136.91
Total Debt	54	100.3	99.51	54	1.19
Net Cash (Debt)	42.23	137.66	70.52	84.35	85.55
Net Cash Growth	-69.33%	95.21%	-16.40%	-1.40%	-39.16%
Net Cash Per Share	0.12	0.43	0.32	0.51	0.59
Book Value	107.54	145.95	93.11	117.12	113.6
Book Value Per Share	0.30	0.46	0.42	0.71	0.78
Tangible Book Value	63	101.41	48.57	72.58	69.05
Tangible Book Value Per Share	0.17	0.32	0.22	0.44	0.47

Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q